TRANSLOCATION RENAL CELL CARCINOMA
Clinical trials for TRANSLOCATION RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSLOCATION RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSLOCATION RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
New drug combo aims to control advanced kidney cancer
Disease control Recruiting nowThis study tests whether combining two drugs, abemaciclib and cabozantinib, is safe and works for people with advanced kidney cancer that has spread. About 43 adults whose cancer did not respond to immunotherapy will receive different doses to find the best one with fewest side e…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New Triple-Drug cocktail aims to shrink Hard-to-Treat kidney tumors
Disease control Recruiting nowThis study is testing whether a combination of three drugs—sasanlimab, palbociclib, and axitinib—can shrink or control advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for tumor r…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 11, 2026 20:39 UTC